KRT8 and neoplasm: Since Amhr2-Cre is also expressed in the ovarian surface epithelium [31], immunofluorescence was performed using antibodies against epithelial cell markers, cytokeratin 8 (KRT8) and 17/19 (KRT17/19), to exclude the epithelial cell identity of the neoplasms.